ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 737

Reliability of Nailfold Capillary Density Measurement As a Possible Outcome Measure for Systemic Sclerosis-Related Microangiopathy

Graham Dinsdale1, Tonia Moore2, Joanne Manning2, Andrea Murray1, Michael Berks3, Philip Tresadern3, Chris Taylor3, Neil O'Leary4, Chris Roberts4, John Allen5, Marina Anderson6, Maurizio Cutolo7, Roger Hesselstrand8, Kevin Howell9, Paula Pyrkotsch6, Francesca Ravera7, Vanessa Smith10, Alberto Sulli7, Marie Wildt8 and Ariane Herrick1, 1Centre for Musculoskeletal Research, University of Manchester, Manchester Academic Health Science Centre, Manchester, United Kingdom, 2Salford Royal Hospital NHS Foundation Trust, Salford, United Kingdom, 3Centre for Imaging Sciences, University of Manchester, Institute of Population Health, Manchester, United Kingdom, 4Centre for Biostatistics, Institute of Population Health, University of Manchester, Manchester, United Kingdom, 5Regional Medical Physics Department, Freeman Hospital, Newcastle upon Tyne, United Kingdom, 6Institute of Ageing and Chronic Disease, University of Liverpool, Liverpool, United Kingdom, 7Research Laboratory and Academic Division of Clinical Rheumatology, Department of Internal Medicine, University of Genova, Genoa, Italy, 8Rheumatology, Lund University, Lund, Sweden, 9Institute of Immunity and Transplantation, University College London, Royal Free Campus, London, United Kingdom, 10Department of Rheumatology, Ghent University Hospital, Ghent, Belgium

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: capillary microscopy, outcome measures and systemic sclerosis, Raynaud's phenomenon

  • Tweet
  • Email
  • Print
Session Information

Title: Systemic Sclerosis, Fibrosing Syndromes and Raynaud's - Clinical Aspects and Therapeutics: Systemic Sclerosis Measures and Outcomes

Session Type: Abstract Submissions (ACR)

Background/Purpose

Nailfold videocapillaroscopy allows non-invasive assessment of the microcirculation. Image annotation software allows tracking of changes over time; a potential outcome measure for systemic sclerosis (SSc) related microangiopathy. Our objective was to assess the reliability of capillary density measurement, known to be reduced in SSc1.

Methods

124 patients (102 SSc, 22 primary Raynaud’s phenomenon [PRP]), and 50 healthy controls (HC), underwent high-magnification (300x) videocapillaroscopy mosaic imaging of all 10 digits (1740 images).

Image subsets, sampled across disease categories, were randomly allocated to each of 10 capillaroscopy experts. These ‘raters’ used custom software to assess images. Each image used in this analysis was assigned to at least 2 raters. To assess intra-rater reliability, each rater performed repeat evaluations on an image subgroup. At least 6 images were assessed from each subject.

Raters marked distal vessel locations in an image. Vessel density was calculated as the total number of distal vessels divided by the Euclidean distance between the vessels at the horizontal extremities.

We examined: (1) the probability of raters marking sufficient (2 or more) distal vessels in an image (logistic mixed-effects model). Conditional on an image evaluation having sufficient distal vessels marked (2) distal vessel density (linear mixed-effects model).

Intra and inter-rater reliability was estimated with intra-class correlation coefficients from fitted model variance components.


Results

3463 images were evaluated. Each rater assessed a median (range) of 112 (87, 1406) unique images from 14 (9, 174) subjects. Same-rater repeat evaluations were performed on (median) 17% of images, and 904 images from 116 patients were evaluated by at least 2 raters.

Raters marked sufficient distal vessels in 79% of evaluations. Compared to HC, SSc and PRP images had odds ratios [95% CI] of sufficient distal vessels marked of 0.23 [0.14, 1.41] and 3.80 [0.37, 5.23] respectively. The mean vessel density in HC was 9.84 vessels/mm. Compared to HC, vessel density was lower in SSc (6.62) but not significantly different in PRP (9.58); respective differences [95% CI] were -3.22 [-3.88, -2.63] and -0.26 [-1.12, 0.63] vessels/mm.

Estimates of intra-rater reliability [95% CI] were 0.91 [0.89, 0.92] for vessel mark-up and 0.89 [0.87, 0.91] for vessel density. Corresponding estimates of inter-rater reliability were 0.51 [0.39, 0.76] and 0.56 [0.47, 0.64] respectively.

Conclusion

Mark-up rate differences between-groups are most likely due to differences in capillary architecture (capillary loss/damage in SSc patients). Density was unmeasurable in a sizable minority (21%) of image evaluations with potential implications for the representativeness of this measure. The high intra-(compared to inter-) rater reliability suggests that density could serve as outcome measure in prospective studies if the same rater examines images. Research on the impact of training on inter-rater reliability, and into more objective (automated) analysis methods is required to further develop this promising outcome measure.

 

  1. Cutolo M et al. Nature Rev Rheumatol 2010;6:578-87

Disclosure:

G. Dinsdale,
None;

T. Moore,
None;

J. Manning,
None;

A. Murray,
None;

M. Berks,
None;

P. Tresadern,
None;

C. Taylor,
None;

N. O’Leary,
None;

C. Roberts,
None;

J. Allen,
None;

M. Anderson,
None;

M. Cutolo,
None;

R. Hesselstrand,
None;

K. Howell,
None;

P. Pyrkotsch,
None;

F. Ravera,
None;

V. Smith,
None;

A. Sulli,
None;

M. Wildt,
None;

A. Herrick,
None.

  • Tweet
  • Email
  • Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/reliability-of-nailfold-capillary-density-measurement-as-a-possible-outcome-measure-for-systemic-sclerosis-related-microangiopathy/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology